Institutional Fund
Perceptive Advisors LLC
New York, NYCIK 12249627 filings on record
Portfolio Value
$5.05B
Q1 2026
Holdings
91
Reported positions
New Buys
18
Opened this quarter
QoQ Change
-7.3%
from $5.44B
Portfolio Value Trend
Reported 13F value by quarter
Portfolio value trend — upgrade to see history
UpgradeTop Allocations
Largest positions by weight
- Praxis Precision Medicines I13.0%
- Celcuity Inc7.1%
- Ascendis Pharma A/S6.9%
- Roivant Sciences Ltd4.5%
- Centessa Pharmaceuticals PLC4.1%
- Rhythm Pharmaceuticals Inc4.1%
- Other60.2%
Portfolio Holdings
91 positions · Q1 2026
| # | Security | Shares | Value | % Port. | Δ Shares | Activity |
|---|---|---|---|---|---|---|
| 1 | Praxis Precision Medicines I | 2.04M | $655.97M | 13.0% | +40.0K | Added |
| 2 | Celcuity Inc | 3.13M | $356.94M | 7.1% | −33.0K | Reduced |
| 3 | Ascendis Pharma A/S | 1.53M | $350.28M | 6.9% | +450.0K | Added |
| 4 | Roivant Sciences Ltd | 8.29M | $229.51M | 4.5% | +300.0K | Added |
| 5 | Centessa Pharmaceuticals PLC | 5.26M | $208.88M | 4.1% | +2.34M | Added |
| 6 | Rhythm Pharmaceuticals Inc | 2.37M | $206.45M | 4.1% | −172.6K | Reduced |
| 7 | Spyre Therapeutics Inc | 3.78M | $190.83M | 3.8% | +714.0K | Added |
| 8 | Nuvalent Inc | 1.58M | $161.92M | 3.2% | −84.6K | Reduced |
| 9 | Edgewise Therapeutics Inc | 4.42M | $139.36M | 2.8% | −34.0K | Reduced |
| 10 | Protagonist Therapeutics Inc | 1.23M | $129.73M | 2.6% | −119.5K | Reduced |
81 more holdings on Premium
See this fund's complete portfolio, full position changes, and activity history.
Unlock full portfolio